These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 36172973)

  • 1. Clinical and imaging clues to the diagnosis and follow-up of ptosis and ophthalmoparesis.
    Keene KR; Kan HE; van der Meeren S; Verbist BM; Tannemaat MR; Beenakker JM; Verschuuren JJGM
    J Cachexia Sarcopenia Muscle; 2022 Dec; 13(6):2820-2834. PubMed ID: 36172973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye Muscle MRI in Myasthenia Gravis and Other Neuromuscular Disorders.
    Keene KR; Notting IC; Verschuuren JJGM; Voermans N; de Keizer ROB; Beenakker JM; Tannemaat MR; Kan HE
    J Neuromuscul Dis; 2023; 10(5):869-883. PubMed ID: 37182896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive bilateral ophthalmoparesis--a case of simultaneous autoimmunity: balancing Graves' ophthalmoparesis and ocular myasthenia.
    Canepa C; Venu M
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26729830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ophthalmologic manifestations in myasthenia gravis: presentation and prognosis.
    Akan O; Baysal-Kirac L
    Acta Neurol Belg; 2021 Oct; 121(5):1131-1140. PubMed ID: 33439450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular Weakness in Myasthenia Gravis: Changes in Affected Muscles are a Distinct Clinical Feature.
    de Meel RHP; Raadsheer WF; van Zwet EW; Tannemaat MR; Verschuuren JJGM
    J Neuromuscul Dis; 2019; 6(3):369-376. PubMed ID: 31424417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inferior oblique muscle paresis as a sign of myasthenia gravis.
    Almog Y; Ben-David M; Nemet AY
    J Clin Neurosci; 2016 Mar; 25():50-3. PubMed ID: 26531848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validation of the ice pack test in ophthalmoparesis due to myasthenia gravis].
    Ramirez-Antunez ÁG; García-Ramos G; Estañol-Vidal B; Juárez-Flores A
    Rev Neurol; 2013 Nov; 57(9):385-95. PubMed ID: 24150950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The feasibility of quantitative MRI of extra-ocular muscles in myasthenia gravis and Graves' orbitopathy.
    Keene KR; van Vught L; van de Velde NM; Ciggaar IA; Notting IC; Genders SW; Verschuuren JJGM; Tannemaat MR; Kan HE; Beenakker JM
    NMR Biomed; 2021 Jan; 34(1):e4407. PubMed ID: 32893386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orbital magnetic resonance imaging of extraocular muscles in chronic progressive external ophthalmoplegia: specific diagnostic findings.
    Ortube MC; Bhola R; Demer JL
    J AAPOS; 2006 Oct; 10(5):414-8. PubMed ID: 17070475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare concurrent ocular myasthenia gravis and Graves' ophthalmopathy in a man with Poland syndrome: a case report.
    Tang J; Qin C
    BMC Neurol; 2020 Dec; 20(1):444. PubMed ID: 33297974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophthalmoplegia associated with anti-GQ1b antibodies: case report and review.
    Yvon C; Nee D; Chan D; Malhotra R
    Orbit; 2023 Apr; 42(2):192-195. PubMed ID: 34493154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the frontline: what an optometrist needs to know about myasthenia gravis.
    Pruitt JA; Ilsen PF
    Optometry; 2010 Sep; 81(9):454-60. PubMed ID: 20655284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Progressive External Ophthalmoplegia in the Absence of Ptosis.
    Bucelli RC; Lee MS; McClelland CM
    J Neuroophthalmol; 2016 Sep; 36(3):270-4. PubMed ID: 27111092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of thyroid associated ophthalmopathy with myasthenia Graves in 12 patients].
    Ji H; Yang J; Zhu H; Jiang W; Sun F
    Zhonghua Yan Ke Za Zhi; 2015 Aug; 51(8):581-5. PubMed ID: 26696574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ptosis in the differential diagnosis of neurologic diseases].
    Hartmann A; Berendes K; Berlit P
    Klin Monbl Augenheilkd; 1983 Feb; 182(2):113-20. PubMed ID: 6405079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of myogenic (myopathic) ptosis.
    Waller RR
    Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol; 1975; 79(5):697-702. PubMed ID: 1242546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Graves ophthalmopathy and ocular myasthenia].
    Widjaja A; Rademaker J; Gölkel C; Holstein A; Leifke E; Wat N
    Ophthalmologe; 2000 Jan; 97(1):38-40. PubMed ID: 10663788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of ocular involvement in myasthenia gravis with MuSK antibodies.
    Evoli A; Alboini PE; Iorio R; Damato V; Bartoccioni E
    J Neurol Neurosurg Psychiatry; 2017 Sep; 88(9):761-763. PubMed ID: 28601810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low probability of myasthenia Gravis in patients presenting to neuro-ophthalmology clinic for evaluation of isolated ptosis.
    Donaldson L; Issa M; Dezard V; Margolin E
    Eur J Ophthalmol; 2023 Jan; 33(1):524-529. PubMed ID: 35686323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.
    Mullaney P; Vajsar J; Smith R; Buncic JR
    Ophthalmology; 2000 Mar; 107(3):504-10. PubMed ID: 10711889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.